Mark Foley

(Mr. Mark Foley)

Currently holds positions in Revance Therapeutics Inc, SI-BONE Inc, ZELTIQ Aesthetics Inc and Revance Therapeutics Inc

Positions
Position Company Period
Independent Director Revance Therapeutics Inc Sept. 5, 2017 -
Independent Director SI-BONE Inc June 17, 2019 -
President, Chief Executive Officer ZELTIQ Aesthetics Inc April 28, 2017 -
President, Chief Executive Officer, Director Revance Therapeutics Inc Oct. 13, 2019 -
Independent Director Revance Therapeutics Inc Sept. 5, 2017 - Oct. 13, 2019
Chairman of the Board, President, Chief Executive Officer ZELTIQ Aesthetics Inc Jan. 1, 2015 - April 28, 2017
President, Chief Executive Officer, Director ZELTIQ Aesthetics Inc Nov. 19, 2012 - Jan. 1, 2015
President, Chief Executive Officer, Interim Chief Financial Officer, Director ZELTIQ Aesthetics Inc Aug. 23, 2012 - Nov. 19, 2012
Interim President, Chief Executive Officer, Interim Chief Financial Officer, Director ZELTIQ Aesthetics Inc Aug. 9, 2012 - Aug. 23, 2012
Interim President and Chief Executive Officer, Director ZELTIQ Aesthetics Inc April 19, 2012 - Aug. 9, 2012
Director ZELTIQ Aesthetics Inc May 1, 2010 - April 19, 2012
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2024-03-08 2024-03-06
B Purchase
30,000 +3.0%
6.98
209,400 USD
30,000 +3.0% 6.98 209,400 USD
2024-02-26 2024-02-23
US Glaukos Corp (GKOS)
S Sale
4,560 -12.1%
92.87
423,487 USD
4,560 -12.1% 92.87 423,487 USD
2023-08-04 2023-08-03
PS Planned sale
26,279 -3.0%
22.57
593,151 USD
26,279 -3.0% 22.57 593,151 USD
2023-07-05 2023-07-03
PS Planned sale
26,279 -2.9%
24.94
655,333 USD
26,279 -2.9% 24.94 655,333 USD
2023-06-13 2023-06-09
PS Planned sale
31,279 -3.4%
30.72
960,928 USD
31,279 -3.4% 30.72 960,928 USD
2023-05-16 2023-05-15
S Sale
70,447 -7.1%
34.55
2,433,725 USD
70,447 -7.1% 34.55 2,433,725 USD
2021-11-29 2021-11-29
B Purchase
40,000 +56.4%
12.90
515,924 USD
40,000 +56.4% 12.90 515,924 USD
2016-03-23 2016-03-22
PS Planned sale
9,698 -2.6%
25.01
242,568 USD
9,698 -2.6% 25.01 242,568 USD
2016-03-22 2016-03-18
PS Planned sale
1,272 -0.3%
25.01
31,816 USD
1,272 -0.3% 25.01 31,816 USD